Orosz A., Hámori J., Falus A., Madarász E., Lakos I., Ádám G.: Specific antibody fragments against the postsynaptic web, In: Nature New Biol 245, 18-19, 1973.
Falus A., Merétey K., Bozsóky S.: Prevalence of anti-beta2-microglobulin autoantibodies in sera of rheumatoid arthritis patients with extraarticular manifestations, In: Ann Rheum Dis, 40, 409-413, 1981.
Fésüs L., Falus A., Erdei A., Laki K.: Human b-2-microglobulin is a substrate of tissue transglutaminase: polymerization in solution and on the cell surface, In: J Cell Biol, 89, 706-710, 1981.
Falus A., Merétey K., Bagdy D., Diószegi M., Böhm U., Csák É., Bozsóky S.: Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation, In: Clin Exper Immunol, 47, 103-109, 1982.
Falus A., Wiik A., Permin H., Brandslund I., Svehag S.E.: High serum beta-2-microglobulin levels and circulating immune complexes containing b2m and anti-b2m antibodies in Felty's syndrome, In: Arthritis and Rheumatism, 26,721-727, 1983.
Falus A., Merétey K.: Effect of histamine on the gene expression and biosynthesis of complement components C2, factor B and C3 in mouse peritoneal macrophages, In: Immunology, 60, 547-551, 1987.
Falus A., Beuscher H.U., Auerbach H.S., Colten H.R.: Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific, In: J of Immunol, 138, 856-860, 1987.
Wheat W.H., Wetsel R., Falus A., Tack B.F., Strunk R.C.: The fifth component of complement (C5) in the mouse, In: J Exp Med, 165, 1442-1447, 1987.
Falus A., Wakeland E.K., McConnell T.J., Gitlin J., Whitehead A.S., Colten H.R.: DNA polymorphism of MHC III genes in inbred and wild mouse strains, In: Immunogenetics, 25, 290-298, 1987.
Fésüs L., Thomazy V., Falus A.: Induction and activation of tissue transglutaminase during programmed cell death, In: FEBS Letters, 224, 104-108, 1987.
Falus A., Merétey K.: Effect of histamine on the gene expression and secretion of complement components C2,factor B and C3 in murine macrophages-an opposite signal processing via H1 and H2 receptors, In: Molecular Immunology, 25, 1093-1097, 1988.
Falus A., Kramer J., Walcz E.,Varga Zs., Sétáló J., Jobst K., Lakatos T., Merétey K.:Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells,human monocytoid and hepatoma derived cell lines, In: Immunology, 68, 133-136, 1989.
Falus A., Merétey K.: Histamine: an early messenger in inflammatory and immune reactions, In: Immunology Today, 13,154-156, 1992.
Falus A., Taga T., Hibi M., Murakami M., Kishimoto T.: Regulation of interleukin-6 receptor and gp130 expression in human cell lines of lymphoid and myeloid origin, In: Cytokine 4, 495-499, 1992.
Falus A.: Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines, In: Immunology, 78, 193-196, 1993.
Falus A.: Histamine modulates acute phase response at multiple points, In: Immunol Today, 15, 596, 1994.
Igaz P., Toth S., Rose-John S., Madurka I., Fejér Gy., Szalai Cs., Falus A.: Soluble interleukin-6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes, In: Cytokine, 10, 620-626, 1998.
Szalai Cs., Császár A., Czinner A., Szabó T., Falus A.: High frequency of the CCR5 deletion sallele in Gypsies living in Hungary, In: Immunol Let, 63, 57-58, 1998.
Szalai Cs., Bojszkó A., Beko G., Falus A.: Prevalence of CCR5s32 in allergic diseases, In: The Lancet, 355, 66, 2000.
Szalai Cs., Toth S., Falus A.: Exon-intron organization of the human gp130 gene, In: Gene 243, 161-6, 2000.
Radvány Z., Darvas Z., Kerekes K., Prechl J., Szalai C., Pállinger É., László V., Varga V.L., Sandor M., Erdei A., Falus A.: H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen specific proliferation of ovalbumin specific murine T cells, In: Seminars in Cancer Biology, 10, 41-45, 2000.
Lázár E., Hegyesi H., Tóth S., Darvas Zs., László V., Szalai Cs., Falus A.:Biosynthesis of interleukin-6, an autocrine growth factor for melanoma is regulated by melanoma derived histamine, In: Seminars in Cancer Biology, 10, 25-28, 2000.
Lázár-Molnár E., Hegyesi H., Tóth S., Falus A.: Autocrine and paracrine regulations by cytokines and growth factors in melanoma, In: Cytokine, 12, 547-554, 2000.
Haak-Frendscho, M., Darvas Zs., Hegyesi H., Kárpáti S., Hoffmann R.L., László V., Bencsáth M., Szalai Cs., Fürész J., Timár J., Bata-Csörgő Z.Zs., Szabad G., Pivarcsi A., Pállinger É., Kemény L., Horváth A., Dobozy A., Falus A.: Histidine decarboxylase immunoreactivity in human melanoma, In: J Invest Dermatol, 115, 345-352, 2000.
Igaz P., Bősze Sz., Tóth S., Falus A., Hudecz F.: C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells, In: Biol Chem, 382, 669-676, 2001.
Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., Tchougounova E., Hellman L., Gertsenstein M., Hirasawa N., Sakurai E., Buzas E., Kovacs P., Csaba G., Kittel A., Okada M., Hara M., Mar L., Numayama-Tsuruta K., Ishigaki-Suzuki S., Ohuchi K., Ichikawa A., Falus A., Watanabe T., Nagy A.: Mice lacking histidine decarboxylase exhibit abnormal mast cells, In: FEBS Lett, 502, 53-56, 2001.
Hegyesi H., Somlai B., Varga V.L., Tóth Gy., Kovács P., Molnár E.L., László V., Kárpáti S., Rivera E., Falus A., Darvas Zs.: Supression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides, In: J Invest Dermatol 117, 151-153, 2001.
Fitzsimons C., Lazar-Molnar E., Tomoskozi Z., Buzás E. , Rivera E.S., Falus A.:Histamine deficiency induces tissue-specific down-regulation of histamine H2 receptor expression in histidine decarboxylase knockout mice, In: FEBS Lett, 508, 245-248, 2001.
Falus A., Hegyesi H., Lázár-Molnár E., Pós Z., László V., Darvas Zs.: Paracrine and autocrine interactions in melanoma; histamine is a relevant player in local regulation, In: Trends in Immunology (formerly Immunology Today) 22, 648-652, 2002.
Tanaka S., Hamada K., Yamada N., Sugita Y., Tonai S., Hunyady B., Palkovits M., Falus A., Watanabe T., Okabe S., Ohtsu H., Ichikawa A., Nagy A.: Gastric Acid Secretion in L-Histidine Decarboxylase-Deficient Mice, In: Gastroenterology 122, 145-155, 2002.
Igaz P., Fitzimons C.P., Szalai Cs., Falus A.: Histamine Genomics In Silico. Polymorphisms of the HUMAN Genes Involved in the Synthesis, Action and Degradation of Histamine, In: Am J Pharmacogenomics 2 , 67-72, 2002.
Wiener Z, Andrásfalvy M, Pállinger É, Kovács P, Szalai Cs, Erdei A, Tóth S, Nagy A,
Falus A: Bone marrow-derived mast cell differentiation strongly reduced in histidine decarboxylase knockout, histamine-free mice, In: International Immunology 14, 381-387, 2002.
Veszely G., Fürész J., Horkay B., Falus A.: Effect of Alpha-FMH and DPPE on Colony-forming properties of human peripheral progenitor cells, In: Curr Med Chem 9, 1349-1357, 2002.
Pap E., Racz K., Kovacs J.K., Varga I., Buzas E., Madarasz B., Foldes C., Szalai C., Watanabe T., Ohtsu H., Ichikawa A., Nagy A., Falus A.: Histidine decarboxylase deficiency in gene knockout mice elevates male sex steroid production, In: J Endocrinol 175, 193-199, 2002.
Lazar-Molnar E., Hegyesi H., Pallinger E., Kovacs P., Toth S., Fitzsimons C.P., Cricco G., Martin G., Bergoc R., Darvas Zs., Rivera E.S., Falus A.: Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6, In: Eur J Clin Invest 32, 743-749, 2002.
Hunyady B., Zólyomi A., Czimmer J., Mocsik G., Kozicz T., Buzas E., Tanaka S., Ichikawa A., Nagy A., Palkovits M., Falus A.: Expanded parietal cell pool in transgenic mice unable to synthetize histamine, In: Scand J. Gastroenterology 38, 133-140, 2003.
Kaczur V., Puskas L.G., Takacs M., Racz I.A., Szendroi A., Toth S., Nagy Z., Szalai C., Balazs C., Falus A., Knudsen B., Farid N.R.: Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize, In: Mol Genet Metab 78, 275-90, 2003.
Fitzpatrick L.A., Buzas E., Gagne T.J., Nagy A., Horvath C., Ferencz V., Mester A., Kari B., Ruan M., Falus A., Barsony J.: Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss, In: Proc Natl Acad Sci U S A. 100, 6027-6032, 2003.
Bosze S., Hudecz F., Igaz P., Ortutay Z., Csik G., Falus A., Toth S.: Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells, In: Biol Chem 384, 409-421, 2003.